Nectar Lifesciences Limited has informed the Exchange regarding a press release dated July 08, 2025, titled "Nectar Lifesciences Announces Strategic Sale of API and Formulations Business to Ceph Lifesciences for ₹1,270 Crores".
Press Release Jul 08 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Nectar Lifesciences Ltd. on 6ix
Earlier from Nectar Lifesciences
All Nectar Lifesciences news releasesFollow Nectar Lifesciences into a list and get an email when it puts out news.
Follow Nectar Lifesciences